In The News

She Didn’t Need to Be Commissioner: Janet Woodcock’s Transformative Legacy

The Pink Sheet

07 Dec 2021

Stacy Cline Amin spoke to The Pink Sheet about Janet Woodcock, who is expected to scale back her role at the U.S. Food and Drug Administration (FDA) following 35 years of service.

According to Stacy, who served as FDA chief counsel from 2018 to 2021 and also interacted with Woodcock in other government roles, Janet “was in command of the room because she was always the most knowledgeable person in the room, she had the best grasp of the facts.”

“Nobody told her what to do…even the Secretary wouldn’t try to tell Janet Woodcock what to do,” Stacy added. “It was always more of a conversation with her or a negotiation with her. She could really see the big picture and was great at shaping reasonable outcomes to challenging situations.”

Read the full article (subscription required).



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.